- Home
- TWIN vs TLSI Comparison
TWIN vs TLSI Comparison
Compare TWIN & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWIN
- TLSI
- Stock Information
- Founded
- TWIN 1918
- TLSI 2010
- Country
- TWIN United States
- TLSI United States
- Employees
- TWIN N/A
- TLSI N/A
- Industry
- TWIN Industrial Machinery/Components
- TLSI Medical Specialities
- Sector
- TWIN Industrials
- TLSI Health Care
- Exchange
- TWIN Nasdaq
- TLSI Nasdaq
- Market Cap
- TWIN 152.3M
- TLSI 124.9M
- IPO Year
- TWIN N/A
- TLSI N/A
- Fundamental
- Price
- TWIN $11.08
- TLSI $4.69
- Analyst Decision
- TWIN
- TLSI Strong Buy
- Analyst Count
- TWIN 0
- TLSI 6
- Target Price
- TWIN N/A
- TLSI $11.75
- AVG Volume (30 Days)
- TWIN 25.7K
- TLSI 36.4K
- Earning Date
- TWIN 02-05-2025
- TLSI 11-14-2024
- Dividend Yield
- TWIN 1.47%
- TLSI N/A
- EPS Growth
- TWIN N/A
- TLSI N/A
- EPS
- TWIN 0.68
- TLSI N/A
- Revenue
- TWIN $304,470,000.00
- TLSI $26,891,000.00
- Revenue This Year
- TWIN N/A
- TLSI $60.96
- Revenue Next Year
- TWIN N/A
- TLSI $53.65
- P/E Ratio
- TWIN $16.24
- TLSI N/A
- Revenue Growth
- TWIN 6.98
- TLSI 67.90
- 52 Week Low
- TWIN $10.22
- TLSI $3.50
- 52 Week High
- TWIN $18.00
- TLSI $10.42
- Technical
- Relative Strength Index (RSI)
- TWIN 42.13
- TLSI 51.68
- Support Level
- TWIN $10.22
- TLSI $4.72
- Resistance Level
- TWIN $11.86
- TLSI $5.32
- Average True Range (ATR)
- TWIN 0.49
- TLSI 0.31
- MACD
- TWIN -0.06
- TLSI 0.01
- Stochastic Oscillator
- TWIN 46.49
- TLSI 47.52
About TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.